Synovus Financial’s Ionis Pharmaceuticals IONS Stock Holding History

Synovus Financial’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-269	Closed	-$12K	–	1847
2020 Q1	$12K	Buy	+269	New	+$15K	﹤0.01%	1512

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Synovus Financial's IONS Position: Q2 2020 in Review

Synovus Financial sold out of Ionis Pharmaceuticals (IONS) in Q2 2020, closing a stake of 269 shares — an estimated $12K sold.

Synovus Financial first reported a position in IONS in Q1 2020 and held it in 1 quarter. The position peaked at $12K in Q1 2020. 375 funds tracked by Wall St. Rank hold IONS as of Q2 2020.

Synovus Financial reported no remaining Ionis Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Synovus Financial sold 269 Ionis Pharmaceuticals shares in Q2 2020, an estimated $12K.
Synovus Financial first reported a position in Ionis Pharmaceuticals in Q1 2020 and held it in 1 quarter.
Synovus Financial's Ionis Pharmaceuticals position peaked at $12K in Q1 2020.
375 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2020.

Based on Synovus Financial's 13F filing for Q2 2020, filed 10 Aug 2020.